OtherClinical Investigations (Human)
18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study
Coreline N. Burggraaff, Jakoba J. Eertink, Pieternella J. Lugtenburg, Otto S. Hoekstra, Anne I.J. Arens, Bart de Keizer, Martijn W. Heymans, Bronno van der Holt, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Henrica C.W. de Vet and Josée M. Zijlstra
Journal of Nuclear Medicine October 2021, jnumed.121.262205; DOI: https://doi.org/10.2967/jnumed.121.262205
Coreline N. Burggraaff
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Jakoba J. Eertink
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Pieternella J. Lugtenburg
2 Erasmus MC Cancer Institute, Netherlands;
Otto S. Hoekstra
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Anne I.J. Arens
3 Radboud University Medical Center, Netherlands;
Bart de Keizer
4 University Medical Center Utrecht, Netherlands
Martijn W. Heymans
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Bronno van der Holt
2 Erasmus MC Cancer Institute, Netherlands;
Sanne E. Wiegers
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Simone Pieplenbosch
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Ronald Boellaard
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Henrica C.W. de Vet
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Josée M. Zijlstra
1 Amsterdam UMC, Vrije Universiteit Amsterdam, Netherlands;
Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study
Coreline N. Burggraaff, Jakoba J. Eertink, Pieternella J. Lugtenburg, Otto S. Hoekstra, Anne I.J. Arens, Bart de Keizer, Martijn W. Heymans, Bronno van der Holt, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Henrica C.W. de Vet, Josée M. Zijlstra
Journal of Nuclear Medicine Oct 2021, jnumed.121.262205; DOI: 10.2967/jnumed.121.262205
18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study
Coreline N. Burggraaff, Jakoba J. Eertink, Pieternella J. Lugtenburg, Otto S. Hoekstra, Anne I.J. Arens, Bart de Keizer, Martijn W. Heymans, Bronno van der Holt, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Henrica C.W. de Vet, Josée M. Zijlstra
Journal of Nuclear Medicine Oct 2021, jnumed.121.262205; DOI: 10.2967/jnumed.121.262205
Jump to section
Related Articles
Cited By...
- Prognostic Value of 18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study
- Prognostic Value of 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen